AIM ImmunoTech, Inc. - AIM Net Assets per Single Share

Public company logo of AIM ImmunoTech, Inc. (AIM)

High R&D costs during immunomodulator trials limit business scaling by increasing unit expenses, yet the unique drug Ampligen provides AIM ImmunoTech (AIM) with strong pricing power due to inelastic demand. The current book value per share on this chart confirms this basis, where the metric value stands at 0.27. Simultaneously, the company is implementing ESG standards by investing in energy-efficient biomaterial storage and the safe disposal of chemicals.

Accounting Value of a Share: aimimmuno.com (AIM) for 07/04/2022 - 10/27/2026

aimimmuno.com - analytical breakdowns and key metrics (AIM)

- price and consensus price forecast:
Price Chart AIM ImmunoTech|AIM - Consensus Target
- market capitalization data:
Market Value AIM ImmunoTech Inc.|AIM - Full Business Value
- book capitalization data:
Book Value per Share AIM ImmunoTech|AIM - Accounting Value of Company|Market Capitalization to Book Value Ratio aimimmuno.com|AIM - Company Total Assets
- debt and liquidity data:
Debt to Equity AIM ImmunoTech|AIM - Long-Term Debt to Capital Coefficient|Short-Term Debt to Equity AIM ImmunoTech Inc.|AIM - Company Total Debt|Debts to Book Capitalization AIM ImmunoTech Inc.
Analysis of all company metrics:AIM ImmunoTech (AIM)
Signature product of AIM ImmunoTech Inc.

AIM ImmunoTech's bet on a full outsource model for drug development minimizes capital expenditures, which is directly reflected in the book value per share. This indicator is calculated as the difference between all company assets and liabilities divided by the number of shares, allowing investors to assess the actual remaining capital per share regardless of market speculation and emotional price volatility.

Competitor analysis

ARGX: Net Assets per Single Share|BNTX: Accounting Value per Share|Net Assets per Single Share Abivax Corp (ABVX)|admabiologics.com (ADMA) - Share Book Value|PTGX - Book Value per Share|Accounting Value of a Share Immunovant Inc|Book Value per Share KNSA|Book Value per Share GRFS (Grifols Biemat)|Net Assets per Single Share Adaptive Biotechnologies|celldex.com - Accounting Value of a Share|AUPH: Net Assets per Single Share|BCRX - Accounting Value per Share|VERA: Book Value per Share|Book Value per Share Dianthus Corp|PHVS - Accounting Value per Share|Accounting Value of a Share AbCellera Corp|TRML (Tourmaline Bio) - Book Value per Share|Net Assets per Share PGEN (Precigen Inc)|Pharming - Net Assets per Single Share|Nektar Corp - Accounting Value per Share|UPB: Net Assets per Single Share|zenasbio.com (ZBIO) - Accounting Value per Share|IMNM: Accounting Value per Share|GOSS (Gossamer Bio Inc) - Book Value per Share|Net Assets per Single Share KalVista Pharmaceuticals Inc (KALV)|Equity per Share Septerna Pharma|Pieris Pharmaceuticals - Book Value per Share|Net Asset Value per Share savarapharma.com (SVRA)|Book Value per Share RIGL (Rigel Pharmaceuticals, Inc.)|Book Value per Share AnaptysBio Inc ANAB|Book Value per Share ATXS (Astria Pharma)|ENGN: Net Assets per Share|RAPT (RAPT Therapeutics, Inc.) - Net Assets per Single Share|Accounting Value per Share Aerovate Therapeutics|ACRS - Accounting Value per Share|Accounting Value of a Share Kyverna Therapeutics Inc.|TLSA (Tiziana Life Sciences PLC) - Book Value per Share|Net Assets per Share CABA (Cabaletta Bio Inc)|Ventyx Biosciences - Net Assets per Single Share|theratech.com - Accounting Value per Share|AVTX: Net Assets per Single Share|Eledon Pharmaceuticals Inc. (ELDN) - Accounting Value per Share|AGEN: Accounting Value per Share|CLYM (Climb Bio, Inc) - Book Value per Share|Net Assets per Single Share Zura Bio Limited (ZURA)|Equity per Share ATYR|Adagene - Net Assets per Single Share|Net Asset Value per Share ikenaoncology.com IMA|Accounting Value per Share Shattuck Labs (STTK)|Book Price of a Share Equillium Inc EQ|CNTB (Connect Pharma) - Book Value per Share|IMUX - Net Asset Value per Share|ATRA (atarabio.com) - Book Value per Share|InflaRx (IFRX) - Accounting Value per Share|XFOR - Book Value per Share|Accounting Value of a Share Adicet|Book Value per Share CELU|Book Value per Share inmunebio.com (INMB)|Book Value per Share BRNS|Kezar Life Sciences Inc. - Net Assets per Share|SABS: Net Assets per Single Share|AKTX: Accounting Value per Share|Net Assets per Single Share enlivex.com (ENLV)|Q32 Bio (QTTB) - Share Book Value|GOVX - Book Value per Share|Accounting Value of a Share Edesa Biotech Inc|Book Value per Share IBIO|Book Value per Share CARM (carismatx.com)|Net Assets per Single Share XTL Biopharmaceuticals|Bolt Biotherapeutics Inc. - Accounting Value of a Share|HCWB: Net Assets per Single Share|APVO - Accounting Value per Share|ADTX: Book Value per Share|Book Value per Share GRI Bio Corporation|XRTX - Accounting Value per Share|Accounting Value of a Share reshapelifesciences.com|REVB (Revelation Biosciences, Inc.) - Book Value per Share|Net Assets per Share INDP (Indaptus Therapeutics Inc)|Scinai - Net Assets per Single Share|CalciMedica Inc - Accounting Value per Share|AFMD: Net Assets per Single Share|Allakos Inc. (ALLK) - Accounting Value per Share|HOOK: Accounting Value per Share|IGMS (IGM Biosciences) - Book Value per Share|Net Assets per Single Share iTeos (ITOS)|Equity per Share Ocean Biomedical Corp|TC Biopharm - Book Value per Share|Net Asset Value per Share thirdharmonicbio.com (THRD)